Mai Capital Management Artivion, Inc. Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
A detailed history of Mai Capital Management transactions in Artivion, Inc. stock. As of the latest transaction made, Mai Capital Management holds 4,550 shares of AORT stock, worth $130,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,550
Previous 4,550
-0.0%
Holding current value
$130,903
Previous $130,000
14.62%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
188Shares Held
38.7MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$191 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$83.5 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$80.4 Million2.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.78MShares$80 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.26MShares$65 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.16B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...